Free Trial

Apellis Pharmaceuticals (APLS) SEC Filings & 10K Form

Apellis Pharmaceuticals logo
$27.57 -0.48 (-1.71%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$27.57 +0.00 (+0.00%)
As of 08/29/2025 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Apellis Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/29/2025
3:19 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2025
4:28 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2025
10:38 AM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2025
9:34 AM
Apellis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
07/31/2025
5:52 AM
Apellis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2025
3:56 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2025
3:10 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2025
3:11 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2025
3:50 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2025
6:09 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
7:49 AM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
9:38 AM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2025
3:10 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
3:15 PM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:05 PM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2025
10:46 AM
Apellis Pharmaceuticals (Issuer)
Boucher Kelley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
10:44 AM
Apellis Pharmaceuticals (Issuer)
Boucher Kelley (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/22/2025
12:19 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
3:42 PM
Apellis Pharmaceuticals (Subject)
Deep Track Capital, LP (Filed by)
Form SCHEDULE 13G
05/12/2025
1:22 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2025
6:01 AM
Apellis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2025
6:33 AM
Apellis Pharmaceuticals (Filer)
Form DEF 14A
04/23/2025
6:35 AM
Apellis Pharmaceuticals (Filer)
Form DEFA14A
04/23/2025
6:36 AM
Apellis Pharmaceuticals (Filer)
Form ARS
04/21/2025
3:23 PM
Apellis Pharmaceuticals (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
6:11 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
11:27 AM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
2:18 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
6:22 AM
Apellis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2025
6:00 AM
Apellis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
12:59 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
2:13 PM
Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2025
9:49 AM
Apellis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
02/03/2025
12:09 PM
Apellis Pharmaceuticals (Subject)
MORGAN STANLEY (Filed by)
Form SCHEDULE 13G
01/30/2025
11:13 AM
Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:15 AM
Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:18 AM
Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:20 AM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:01 AM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:03 AM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:07 AM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
When the levee breaks (Ad)

The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.tc pixel

Click here to watch the urgent broadcast and get ahead of what’s coming.
01/30/2025
11:10 AM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
11:12 AM
Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
2:42 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:18 PM
Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:22 PM
Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:26 PM
Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:11 PM
Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:12 PM
Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:16 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:16 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
2:17 PM
Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2025
2:37 PM
Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:39 PM
Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:41 PM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:23 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:25 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:26 PM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:28 PM
Apellis Pharmaceuticals (Issuer)
Francois Cedric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:29 PM
Apellis Pharmaceuticals (Issuer)
Lewis Karen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:31 PM
Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
2:19 PM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
3:00 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:39 PM
Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:42 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:43 PM
Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:44 PM
Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:45 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:45 PM
Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:51 PM
Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:52 PM
Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
2:56 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
2:56 PM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
2:59 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
2:54 PM
Apellis Pharmaceuticals (Issuer)
Baumal Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
3:38 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
3:20 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
3:27 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
3:29 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2025
3:22 PM
Apellis Pharmaceuticals (Issuer)
Nicholson Nur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:25 PM
Apellis Pharmaceuticals (Issuer)
Sullivan Timothy Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:29 PM
Apellis Pharmaceuticals (Issuer)
Townsend Adam J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:30 PM
Apellis Pharmaceuticals (Issuer)
Watson David O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:09 PM
Apellis Pharmaceuticals (Issuer)
Chopas James George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:10 PM
Apellis Pharmaceuticals (Issuer)
DeLong Mark Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:14 PM
Apellis Pharmaceuticals (Issuer)
Deschatelets Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:15 PM
Apellis Pharmaceuticals (Issuer)
Eisele Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:55 PM
Apellis Pharmaceuticals (Subject)
Chopas James George (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
4:56 PM
Apellis Pharmaceuticals (Subject)
DeLong Mark Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:00 PM
Apellis Pharmaceuticals (Subject)
Deschatelets Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:02 PM
Apellis Pharmaceuticals (Subject)
Francois Cedric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis (Ad)

With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.tc pixel

Claim your free copy of “How to Survive the Next Financial Crisis” today
01/13/2025
5:02 PM
Apellis Pharmaceuticals (Subject)
Watson David O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:05 PM
Apellis Pharmaceuticals (Subject)
Nicholson Nur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:07 PM
Apellis Pharmaceuticals (Subject)
Eisele Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:09 PM
Apellis Pharmaceuticals (Subject)
Townsend Adam J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:13 PM
Apellis Pharmaceuticals (Subject)
Sullivan Timothy Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:15 PM
Apellis Pharmaceuticals (Subject)
Lewis Karen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
8:08 AM
Apellis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
4:38 PM
Apellis Pharmaceuticals (Issuer)
Walbert Keli (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/10/2025
4:39 PM
Apellis Pharmaceuticals (Issuer)
Walbert Keli (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:APLS) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners